ALLO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $1.50

Kapitalisasi Pasar (MRQ) $518M

P/E -1.8

EPS $-0.87

Pendapatan $0

ROE -59.9%

Rentang 52M $1–$4

ALLO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$0

2022-12-31 → 2025-12-31

EPS$-0.87

2022-12-31 → 2025-12-31

Arus Kas Bebas$-150M

2023-12-31 → 2025-12-31

Margin bersih·

2023-12-31 → 2024-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
P/E	-1.8rata-rata 5T ≈-1.6	≈-1.6	·	·
P/B (MRQ)	1.2rata-rata 5T ≈1.1	≈1.1	4.7	Kurang nilai
Harga / FCF (TTM)	-5.0rata-rata 5T ≈-2.2	≈-2.2	·	·
Harga / Arus Kas (TTM)	-5.1rata-rata 5T ≈-2.2	≈-2.2	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	1.3rata-rata 5T ≈1.1	≈1.1	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
ROA	-39.6%rata-rata 5T ≈-43.7%	≈-43.7%	-39.6%	Sejajar
ROE	-59.9%rata-rata 5T ≈-59.3%	≈-59.3%	-45.6%	Lemah
ROIC	-71.5%	·	-35.8%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		10.7rata-rata 5T ≈9.6	≈9.6	11.8	Sejajar
Quick Ratio (Rasio Cepat)		1.6rata-rata 5T ≈2.0	≈2.0	11.5	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	Tren 5 Tahun	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)		-76.8%	·	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)		-94.2%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-0.87rata-rata 5T ≈$-1.43	≈$-1.43	·	·
Revenue / Share (Pendapatan / Saham)	$0.00rata-rata 5T ≈$0.00	≈$0.00	·	·
Cash Flow / Share (Arus Kas / Saham)	$-0.68rata-rata 5T ≈$-1.07	≈$-1.07	·	·
Cash / Share (Kas / Saham)	$0.23rata-rata 5T ≈$0.36	≈$0.36	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	Tren 5 Tahun	ALLO	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)		0.0rata-rata 5T ≈0.0	≈0.0	0.0	Lemah
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)		≈$0.00	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 15.9%

Laporan Berikutnya Nov 04, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 12, 2026	$-0.13	$-0.17	25.5%
31 Maret 2026	Mei 13, 2026	$-0.18	$-0.19	7.3%
31 Des. 2025		$-0.17	$-0.22	23.0%
30 Sep. 2025		$-0.19	$-0.23	16.6%
30 Juni 2025		$-0.23	$-0.28	17.6%
31 Maret 2025		$-0.28	$-0.30	5.2%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 15

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
R&D Expense	$150M	$192M	$243M	$256M	$220M	$193M	$145M
SG&A Expense	$57M	$65M	$72M	$79M	$74M	$65M	$57M
Operating Expenses	$209M	$273M	$328M	$336M	$294M	$258M	$202M
Operating Income	$-209M	$-273M	$-328M	$-336M	$-180M	$-258M	$-202M
Interest Expense	·	·	·	·	·	$0	$0
Other Non-op	$215.0K	$-4M	$-18M	$-9M	$-4M	$-67M	$17M
Pretax Income	$-191M	$-257M	$-327M	·	$-257M	$-250M	$-185M
Income Tax	$0	$443.0K	$0	$0	$0	$0	$-331.0K
Net Income	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
EPS (Basic)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
EPS (Diluted)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
Shares (Basic)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
Shares (Diluted)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
EBITDA	$-197M	$-260M	$-314M	·	$-245M	$-251M	$-197M

Neraca 21

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$52M	$75M	$83M	$62M	$173M	$183M	$175M
Short-term Investments	·	·	·	·	$284M	$645M	$355M
Prepaid Expense	$8M	$11M	$10M	$12M	$14M	$17M	$14M
Current Assets	$258M	$303M	$459M	$529M	$471M	$845M	$545M
PP&E (Net)	$73M	$86M	$99M	$113M	$123M	$119M	$56M
PP&E (Gross)	$145M	$149M	$151M	$150M	$146M	$132M	$62M
Accum. Depreciation	$73M	$63M	$51M	$37M	$23M	$13M	$5M
Intangibles	·	·	·	·	·	$0	$151.0K
Other Non-current Assets	$4M	$2M	$7M	$10M	$6M	$5M	$5M
Total Assets	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Accounts Payable	$4M	$5M	$6M	$14M	$10M	$10M	$9M
Current Liabilities	$33M	$36M	$37M	$54M	$48M	$94M	$33M
Capital Leases	$75M	$83M	$88M	$95M	$70M	$51M	$51M
Other Non-current Liabilities	$16M	$8M	$5M	$6M	$8M	$3M	$4M
Total Liabilities	$123M	$127M	$131M	$155M	$126M	$148M	$89M
Common Stock	$229.0K	$212.0K	$169.0K	$144.0K	$142.0K	$140.0K	$124.0K
Retained Earnings	$-2.01B	$-1.82B	$-1.56B	$-1.23B	$-895M	$-713M	$-396M
AOCI	$269.0K	$-89.0K	$-955.0K	$-10M	$-3M	$268.0K	$1M
Stockholders' Equity	$293M	$422M	$512M	$667M	$925M	$1.01B	$629M
Liabilities + Equity	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Shares Outstanding	229,413,523	212,210,597	168,642,238	144,438,304	142,623,065	140,474,305	124,267,358

Arus Kas 15

Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$12M	$14M	$14M	$14M	$10M	$7M	$5M
Stock-based Comp	$38M	$52M	$66M	$84M	$81M	$65M	$46M
Deferred Tax	$0	$443.0K	$0	·	·	·	·
Amort. of Intangibles	·	·	·	$0	$0	$151.0K	$603.0K
Restructuring	$5M	·	·	·	·	·	·
Other Non-cash	$-8M	$-9M	$9M	·	$-19M	$62M	$-3M
Operating Cash Flow	$-149M	$-200M	$-238M	$-221M	$-185M	$-115M	$-137M
CapEx	$386.0K	$694.0K	$2M	$5M	$21M	$66M	$51M
Investing Cash Flow	$96M	$76M	$163M	$106M	$164M	$-505M	$164M
Stock Issued	·	·	$91M	$0	$0	$596M	$0
Net Stock Activity	·	·	$91M	·	$0	$622M	$54M
Financing Cash Flow	$30M	$117M	$96M	$3M	$12M	$634M	$59M
Net Change in Cash	$-24M	$-8M	$21M	$-111M	$-9M	$13M	$86M
Free Cash Flow	$-150M	$-201M	$-239M	·	$-206M	$-181M	$-188M
Levered FCF	·	·	·	·	·	$-181M	$-188M

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	·	-1241813.6%	-344986.3%	·	-664.6%	·	·
Net Margin	·	-1170863.6%	-344489.5%	·	-667.7%	·	·
Pretax Margin	·	-1168850.0%	·	·	-667.7%	·	·
EBITDA Margin	·	-1179818.2%	-330039.0%	·	-637.3%	·	·
ROA	-39.6%	-43.2%	-48.3%	·	-22.7%	-25.7%	-24.8%
ROE	-59.9%	-58.1%	-59.9%	·	-27.3%	-22.8%	-29.6%
ROIC	-71.5%	-64.8%	·	·	-27.9%	-23.9%	-32.1%

Likuiditas & Solvabilitas 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.9	8.5	12.4	·	9.8	9.0	16.5
Quick Ratio		1.6	2.1	2.2	·	9.5	8.8	16.0

Efisiensi 1

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	·	0.0	·	·

Per Saham 6

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$1.28	$1.99	$3.04	·	$6.43	$7.69	$5.06
Revenue / Share	$0.00	$0.00	$0.00	·	$0.28	·	·
Cash Flow / Share	$-0.68	$-1.03	$-1.51	·	$-1.36	·	·
Cash / Share	$0.23	$0.35	$0.49	·	$1.22	$1.31	$1.41
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (TTM)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83

Tingkat Pertumbuhan 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Revenue YoY		·	-76.8%	-39.1%	-99.9%	·	·	·
Revenue CAGR 3Y		·	-94.2%	·	·	·	·	·

Valuasi (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
Net Income TTM	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
Market Cap	$314M	$452M	$541M	·	$2.13B	$3.55B	$3.23B
P/E	-1.6	-1.6	-1.5	-2.6	-11.1	-9.6	-14.2
P/S	·	20545.8	5698.3	·	18.7	·	·
P/B	1.1	1.1	1.1	·	2.3	3.3	5.1
P / Tangible Book	1.1	1.1	1.1	1.4	2.3	3.5	·
P / Cash Flow	-2.1	-2.3	-2.3	·	-11.5	-30.8	-23.5
P / FCF	-2.1	-2.2	-2.3	·	-10.3	-19.6	-17.2
Earnings Yield	-63.5%	-62.0%	-65.1%	-37.8%	-9.0%	-10.4%	-7.0%

Laporan Laba Rugi 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$5M	·	$0	$0	$0	$0	$0	$0	$0	$22.0K	$21.0K	$22.0K	$22.0K	$30.0K	$-40.0K	$27.0K
R&D Expense	$31M	$32M	$29M	$31M	$40M	$50M	$45M	$45M	$50M	$52M	$55M	$46M	$62M	$80M	$75M	$64M
SG&A Expense	$21M	$14M	$14M	$14M	$14M	$15M	$16M	$16M	$16M	$17M	$17M	$17M	$19M	$19M	$21M	$19M
Operating Expenses	$52M	$46M	$42M	$45M	$57M	$65M	$60M	$72M	$71M	$70M	$85M	$63M	$81M	$99M	$96M	$83M
Operating Income	$-47M	$-46M	$-42M	$-45M	$-57M	$-65M	$-60M	$-72M	$-71M	$-70M	$-85M	$-63M	$-81M	$-99M	$-96M	$-83M
Other Non-op	$-61.0K	$212.0K	$247.0K	$-81.0K	$-43.0K	$92.0K	$-2M	$-1M	$85.0K	$-929.0K	$-12M	$-5M	$-2M	$2M	$-10M	$-3M
Net Income	$-43M	$-43M	$-39M	$-41M	$-51M	$-60M	$-60M	$-66M	$-66M	$-65M	$-86M	$-62M	$-79M	$-100M	$-103M	$-84M
EPS (Basic)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
EPS (Diluted)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
Shares (Basic)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
Shares (Diluted)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
EBITDA	$-47M	$-43M	·	$-45M	$-57M	$-62M	·	$-72M	$-71M	$-70M	·	$-63M	$-81M	$-99M	·	$-82M

Neraca 19

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$39M	$30M	$52M	$38M	$52M	$42M	$75M	$51M	$171M	$51M	$83M	$69M	$155M	$110M	$62M	$74M
Prepaid Expense	$7M	$6M	$8M	$9M	$10M	$12M	$11M	$13M	$12M	$11M	$10M	$8M	$10M	$10M	$12M	$17M
Current Assets	$340M	$273M	$258M	$261M	$283M	$292M	$303M	$304M	$457M	$395M	$459M	$473M	$502M	$481M	$529M	$569M
PP&E (Net)	$67M	$70M	$73M	$76M	$79M	$83M	$86M	$89M	$92M	$96M	$99M	$103M	$106M	$110M	$113M	$114M
PP&E (Gross)	$145M	$145M	$145M	$145M	$146M	$149M	$149M	$149M	$148M	$151M	$151M	$150M	$150M	$150M	$150M	$149M
Accum. Depreciation	$78M	$75M	$73M	$70M	$67M	$66M	$63M	$60M	$56M	$55M	$51M	$48M	$44M	$40M	$37M	$35M
Other Non-current Assets	$4M	$4M	$4M	$4M	$4M	$2M	$2M	$5M	$6M	$5M	$7M	$10M	$9M	$9M	$10M	$9M
Total Assets	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Accounts Payable	$6M	$5M	$4M	$4M	$5M	$5M	$5M	$6M	$13M	$6M	$6M	$6M	$10M	$15M	$14M	$11M
Current Liabilities	$32M	$28M	$33M	$32M	$32M	$30M	$36M	$33M	$37M	$31M	$37M	$38M	$55M	$60M	$54M	$49M
Capital Leases	$70M	$73M	$75M	$77M	$79M	$81M	$83M	$85M	$87M	$89M	$88M	$90M	$92M	$94M	$95M	$97M
Other Non-current Liabilities	$12M	$16M	$16M	$15M	$15M	$11M	$8M	$8M	$8M	$5M	$5M	$1M	$2M	$2M	$6M	$2M
Total Liabilities	$114M	$117M	$123M	$124M	$126M	$123M	$127M	$125M	$132M	$125M	$131M	$129M	$148M	$155M	$155M	$148M
Common Stock	$345.0K	$245.0K	$229.0K	$223.0K	$220.0K	$219.0K	$212.0K	$210.0K	$209.0K	$170.0K	$169.0K	$168.0K	$167.0K	$146.0K	$144.0K	$144.0K
Retained Earnings	$-2.10B	$-2.05B	$-2.01B	$-1.97B	$-1.93B	$-1.88B	$-1.82B	$-1.76B	$-1.69B	$-1.63B	$-1.56B	$-1.47B	$-1.41B	$-1.33B	$-1.23B	$-1.14B
AOCI	$-518.0K	$-183.0K	$269.0K	$235.0K	$-45.0K	$43.0K	$-89.0K	$157.0K	$-780.0K	$-927.0K	$-955.0K	$-2M	$-4M	$-6M	$-10M	$-13M
Stockholders' Equity	$436M	$279M	$293M	$315M	$345M	$385M	$422M	$464M	$515M	$461M	$512M	$583M	$623M	$592M	$667M	$740M
Liabilities + Equity	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Shares Outstanding	345,345,427	244,816,413	229,413,523	223,163,672	220,133,876	218,598,262	212,210,597	209,500,137	209,049,485	170,452,967	168,642,238	168,175,221	167,133,664	145,740,333	144,438,304	144,031,588

Arus Kas 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$4M	·	·	·	·
Stock-based Comp	$12M	$8M	$8M	$9M	$9M	$12M	$13M	$13M	$14M	$12M	$15M	$15M	$17M	$19M	$17M	$21M
Restructuring	·	·	$0	$0	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$19M	·	·	·	$-8M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-32M	$-13M	$-28M	$-30M	$-39M	$-53M	$-37M	$-44M	$-64M	$-56M	$-54M	$-56M	$-62M	$-67M	$-62M	$-48M
CapEx	$150.0K	$9.0K	$0	$243.0K	$44.0K	$99.0K	$257.0K	$429.0K	$0	$8.0K	$181.0K	$12.0K	$288.0K	$1M	$2M	$223.0K
Investing Cash Flow	$-148M	$-30M	$34M	$12M	$44M	$6M	$55M	$-76M	$75M	$22M	$67M	$-34M	$17M	$113M	$50M	$25M
Stock Issued	·	·	·	·	·	$10M	·	·	·	$0	·	$3M	·	·	$0	$0
Net Stock Activity	·	·	·	·	·	$10M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$188M	$21M	$8M	$3M	$5M	$14M	$6M	$679.0K	$109M	$2M	$155.0K	$4M	$90M	$2M	$46.0K	$1M
Net Change in Cash	$8M	$-21M	$14M	$-15M	$10M	$-33M	$24M	$-119M	$120M	$-32M	$14M	$-86M	$45M	$48M	$-12M	$-22M
Free Cash Flow	·	$-13M	·	·	·	$-53M	·	·	·	$-56M	·	·	·	$-68M	·	·

Profitabilitas 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
Net Margin	-919.8%	·	·	·	·	·	·	·	·	-295454.6%	·	-142593.0%	-177247.7%	-189815.4%	·	-169689.8%
EBITDA Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
ROA	-8.4%	-9.4%	·	-8.1%	-9.1%	-10.9%	·	-10.2%	-9.4%	-9.8%	·	-7.7%	-9.1%	-11.5%	·	-8.5%
ROE	-10.9%	-12.8%	·	-10.6%	-11.8%	-14.1%	·	-12.7%	-11.7%	-12.3%	·	-9.3%	-10.9%	-13.6%	·	-9.7%

Likuiditas & Solvabilitas 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		10.7	9.6	·	8.2	8.9	9.7	·	9.3	12.3	12.8	·	12.6	9.2	8.1	·	11.6
Quick Ratio		1.2	1.1	·	1.2	1.7	1.4	·	1.6	4.6	1.7	·	1.8	2.8	1.8	·	1.5

Efisiensi 1

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.26	$1.14	·	$1.41	$1.57	$1.76	·	$2.21	$2.46	$2.71	·	$3.47	$3.73	$4.06	·	$5.14
Revenue / Share	$0.01	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
Cash Flow / Share	·	$-0.05	·	·	·	$-0.25	·	·	·	$-0.33	·	·	·	$-0.46	·	·
Cash / Share	$0.11	$0.12	·	$0.17	$0.24	$0.19	·	$0.24	$0.82	$0.30	·	$0.41	$0.93	$0.75	·	$0.52
EPS (TTM)	$-0.67	$-0.77	·	$-0.97	$-1.10	$-1.22	·	$-1.54	$-1.59	$-1.78	·	$-2.32	$-2.54	$-2.56	·	$-1.70

Valuasi (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	$0	·	$0	$0	$0	·	$43.0K	$65.0K	$87.0K	·	$34.0K	$39.0K	$81.0K	·	$76M
Net Income TTM	$-165M	$-174M	·	$-212M	$-237M	$-252M	·	$-283M	$-279M	$-292M	·	$-344M	$-366M	$-367M	·	$-243M
Market Cap	$718M	$597M	·	$277M	$249M	$319M	·	$587M	$487M	$762M	·	$533M	$831M	$720M	·	$1.56B
P/E	-3.1	-3.2	·	-1.3	-1.0	-1.2	·	-1.8	-1.5	-2.5	·	-1.4	-2.0	-1.9	·	-6.4
P/S	·	·	·	·	·	·	·	13641.9	7493.6	8757.8	·	15679.9	21298.8	8888.4	·	20.5
P/B	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Tangible Book	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Cash Flow	·	-46.3	·	·	·	-6.0	·	·	·	-13.6	·	·	·	-10.8	·	·
Earnings Yield	-32.2%	-31.6%	·	-78.2%	-97.4%	-83.6%	·	-55.0%	-68.2%	-39.8%	·	-73.2%	-51.1%	-51.8%	·	-15.7%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Pendapatan	$0	$22.0K	$95.0K	·	·
Margin Operasi %	·	-1241813.6%	-344986.3%	·	·
Laba Bersih	$-191M	$-258M	$-327M	·	·
EPS Dilusian	$-0.87	$-1.32	$-2.09	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Rasio Lancar	7.9	8.5	12.4	·	·
Rasio Cepat	1.6	2.1	2.2	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Arus Kas Bebas	$-150M	$-201M	$-239M	·	·

Pemilik institusional (13F) 228 pengaju · $652.3M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 228

Nilai yang dipegang $652.3M

Posisi baru 34

Posisi yang keluar 27

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
34 (-18 vs Kuartal sebelumnya)	27 (+16 vs Kuartal sebelumnya)	100 (+19 vs Kuartal sebelumnya)	51 (+10 vs Kuartal sebelumnya)	+129.2M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$62.705.681	30.146.963	9,61%	Saham
Pfizer Inc	$46.928.245	22.032.040	7,19%	Saham
Frazier Life Sciences Management, L.P.	$46.689.069	22.446.668	7,16%	Saham
STATE STREET CORP	$39.573.718	19.025.826	6,07%	Saham
TPG GP A, LLC	$38.929.916	18.716.306	5,97%	Saham
Sio Capital Management, LLC	$27.712.736	13.323.431	4,25%	Saham
PRIMECAP MANAGEMENT CO/CA/	$27.296.756	13.123.440	4,18%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$25.306.603	12.166.636	3,88%	Saham
FMR LLC	$24.978.809	12.009.043	3,83%	Saham
CITADEL ADVISORS LLC	$20.982.562	10.087.770	3,22%	Saham
TWO SIGMA INVESTMENTS, LP	$16.191.444	7.784.348	2,48%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$14.666.040	7.049.328	2,25%	Saham
GOLDMAN SACHS GROUP INC	$12.789.834	6.148.959	1,96%	Saham
VANGUARD GROUP INC	$12.674.704	9.251.609	1,94%	Saham
GordonMD Global Investments LP	$11.019.840	5.298.000	1,69%	Saham
MARSHALL WACE, LLP	$10.598.449	5.095.408	1,62%	Saham
Patient Square Capital LP	$10.504.000	5.050.000	1,61%	Saham
Aberdeen Group plc	$10.403.644	5.001.752	1,60%	Saham
MILLENNIUM MANAGEMENT LLC	$10.075.289	4.843.889	1,54%	Saham
D. E. Shaw & Co., Inc.	$9.798.329	4.710.735	1,50%	Saham
MORGAN STANLEY	$9.380.720	4.509.962	1,44%	Saham
Woodline Partners LP	$9.361.298	4.500.624	1,44%	Saham
Candriam S.C.A.	$9.010.818	4.336.296	1,38%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$8.761.122	4.212.078	1,34%	Saham
RENAISSANCE TECHNOLOGIES LLC	$7.975.369	3.834.312	1,22%	Saham
Walleye Capital LLC	$6.797.465	3.268.012	1,04%	Saham
RTW INVESTMENTS, LP	$6.760.000	3.250.000	1,04%	Saham
DIMENSIONAL FUND ADVISORS LP	$6.740.207	3.239.077	1,03%	Saham
BANK OF AMERICA CORP /DE/	$6.629.626	3.187.320	1,02%	Saham
UBS Group AG	$6.319.855	3.038.392	0,97%	Saham
Ghisallo Capital Management LLC	$6.240.000	3.000.000	0,96%	Saham
NORTHERN TRUST CORP	$6.146.986	2.955.282	0,94%	Saham
Wildcat Capital Management, LLC	$6.075.237	2.920.787	0,93%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.730.675	2.274.363	0,73%	Saham
AQR CAPITAL MANAGEMENT LLC	$4.173.079	2.006.288	0,64%	Saham
DAFNA Capital Management LLC	$4.160.000	2.000.000	0,64%	Saham
TWO SIGMA ADVISERS, LP	$3.959.574	2.890.200	0,61%	Saham
VANGUARD FIDUCIARY TRUST CO	$3.823.756	1.838.344	0,59%	Saham
JPMORGAN CHASE & CO	$3.193.323	1.438.434	0,49%	Saham
Boxer Capital Management, LLC	$3.120.000	1.500.000	0,48%	Saham
JACOBS LEVY EQUITY MANAGEMENT, INC	$3.026.614	1.455.103	0,46%	Saham
Raiffeisen Bank International AG	$2.442.000	1.100.000	0,37%	Saham
Vida Ventures Advisors, LLC	$2.229.722	1.798.163	0,34%	Saham
Invesco Ltd.	$1.607.395	772.786	0,25%	Saham
Bank of New York Mellon Corp	$1.512.540	727.182	0,23%	Saham
Man Group plc	$1.459.954	701.901	0,22%	Saham
RAYMOND JAMES FINANCIAL INC	$1.412.262	678.972	0,22%	Saham
Nuveen, LLC	$1.299.268	624.648	0,20%	Saham
IEQ CAPITAL, LLC	$1.207.172	580.371	0,19%	Saham
Mitsubishi UFJ Asset Management Co., Ltd.	$1.138.153	547.189	0,17%	Saham

Tampilkan semua 228 pemilik institusional →

Aktivis & pemilik 5%+ 6 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
James G. Coulter, Jon Winkelried, TPG GP A, LLC	30 Sep. 2026	0,00%	Amandemen	·	SEC
Pfizer Inc.	13 Feb. 2026	9,00%	Amandemen	·	SEC
Pfizer Inc. (“Pfizer”) ×3 pengajuan	25 Okt. 2023	·	Pengajuan awal	·	SEC
TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried	18 Jan. 2022	·	Pengajuan awal	·	SEC
TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 pengajuan	10 Agu 2020	·	Pengajuan awal	·	SEC
Pfizer Inc. (“ Pfizer ”)	22 Okt. 2018	·	Pengajuan awal	Investasi pasif	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 23 orang dalam · 13 pejabat · 8 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Zachary Roberts	President and CEO	1 Juli 2026 A	581.166	2	$-104.169
David D Chang	President and CEO	16 Maret 2026 S	5.150.599	2	$-289.459
Geoffrey M. Parker	CHIEF FINANCIAL OFFICER	2 Feb. 2026 A	1.252.795	2	$-88.539
Eric Thomas Schmidt	Chief Financial Officer	22 Maret 2023 A	862.439	0	$0
Earl Martin Douglas	SVP, General Counsel	21 Agu 2026 S	488.267	2	$-103.262
Annie Yoshiyama	SVP, Finance	21 April 2026 S	124.517	2	$-29.311
Benjamin Machinas Beneski	SVP, Chief Technical Officer	31 Maret 2026 S	195.338	5	$-51.672
Timothy L. Moore	Chief Technical Officer	3 Feb. 2025 S	250.713	0	$0
Yinlin Jack Chen	SVP, Finance	10 Agu 2023 A	88.881	0	$0
Lillian Smith	VP, Corporate Counsel	1 April 2023 A	140.390	0	$0
Alison Moore	Chief Technical Officer	22 Maret 2023 A	672.731	0	$0
Veer Bhavnagri	General Counsel	14 Maret 2023 F	556.049	0	$0
Rafael Amado	EVP of R&D	7 Okt. 2022 F	541.946	0	$0
Stephen Mayo	Direktur	18 Juni 2026 A	25.328	0	$0
Elizabeth A. Barrett	Direktur	18 Juni 2026 A	·	0	$0
Deborah M. Messemer	Direktur	18 Juni 2026 A	107.431	0	$0
Owen N. Witte	Direktur	18 Juni 2026 A	292.832	0	$0
Franz B Humer	Direktur	18 Juni 2026 A	307.507	0	$0
Joshua A Kazam	Direktur	18 Juni 2026 A	398.463	0	$0
Vicki L Sato	Direktur	18 Juni 2026 A	162.575	0	$0
PF Equity Holdings 2 B.V.	Pemilik 10%	31 Maret 2022 J	0	0	$0
Pfizer Inc.	Pemilik 10%	15 Okt. 2018 C	22.032.040	0	$0
Arie Belldegrun	·	2 Feb. 2026 A	2.236.816	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 22 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
BBC · ETFis Series Trust I	0,66%	163.586 NS	31 Juli 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,16%	412.615 NS	31 Juli 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,05%	496.849 SH	19 Agu 2026	Harian
PWS · Pacer Funds Trust	0,04%	5.637 NS	31 Juli 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	685.430 SH	1 Okt. 2026	Harian
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	231.043 SH	19 Agu 2026	Harian
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	24.445 SH	1 Okt. 2026	Harian
IBB · iShares Trust	0,03%	1.977.547 SH	11 Sep. 2026	Harian
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	1.528.157 SH	19 Agu 2026	Harian
OMFS · Invesco Exchange-Traded Self-Indexe…	0,02%	27.831 SH	1 Okt. 2026	Harian
IWM · iShares Trust	0,02%	6.789.955 SH	11 Sep. 2026	Harian
DFAS · Dimensional ETF Trust	0,01%	1.028.485 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	3.222.860 SH	19 Agu 2026	Harian
VHT · VANGUARD WORLD FUND	0,01%	776.881 SH	19 Agu 2026	Harian
DFAC · Dimensional ETF Trust	0,00%	241.276 NS	31 Juli 2026	N-PORT
ITOT · iShares Trust	0,00%	356.622 SH	11 Sep. 2026	Harian
DFUS · Dimensional ETF Trust	0,00%	71.758 NS	31 Juli 2026	N-PORT
IWV · iShares Trust	0,00%	25.550 SH	3 Sep. 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	8.666.591 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	22.307 SH	19 Agu 2026	Harian
IWN · iShares Trust	·	2.464.664 SH	11 Sep. 2026	Harian
SMLF · iShares Trust	·	484.475 SH	11 Sep. 2026	Harian

ALLO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 18 analis BELI

Target median $9.00 +500,0%

6 33,3% Beli Kuat

10 55,6% Beli

2 11,1% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

9 analis · 2026-10-03

Target rata-rata $9.00 +500,0%

← Di bawah semua target Harga saat ini $1.50

Rendah$4.00 Rata-rata$9.00 Tinggi$14.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
ALLO	$314M	-1.6	-76.8%	·	-59.9%	·
SGMT	·	-3.7	·	·	-42.3%	·
CTMX	$725M	·	-44.8%	-22.8%	-15.9%	·
PRME	$626M	-2.6	55.3%	-4342.4%	-221.4%	·
ALT	$400M	-3.6	105.0%	-214861.0%	-45.6%	·
MPLT	$773M	-0.9	·	·	-151.1%	·
MNPR	·	·	·	·	·	·
CBIO	$327M	-24.2	-86.7%	-1419.6%	-90.0%	·
NGNE	$319M	-4.9	·	·	-33.6%	·
ZURA	·	·	·	·	·	·
CAPR	$1.66B	-12.8	-11.6%	·	-51.1%	·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Allogene Therapeutics (ALLO): 10 Saham Pertumbuhan Terbaik di Bawah $10 untuk Diinvestasikan Yahoo Finance · 5 bulan, 1 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

ALLO Allogene Therapeutics, Inc. - Common Stock